Medartis Advances Strategic Expansion in US Market

Medartis reported 1H21 orthopedic revenue of CHF 73.6 million (USD $83.2 million), +29.1% vs. 1H20. The company exceeded its 1H19 revenue by 14.1%.

Growth contributions came from all segments and sales regions, but Medartis called out key gains in its key priority target market of the United States. Foot and ankle sales were particularly...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us